Curcumin, a yellow polyphenol derived from turmeric, has potent anti-cancer properties but is limited by poor solubility and bioavailability. To overcome these challenges, researchers developed "nanocurcumin," a polymeric nanoparticle-encapsulated formulation of curcumin. This formulation allows curcumin to be dispersed in aqueous media, enhancing its therapeutic potential. The nanoparticles were synthesized using cross-linked and random copolymers of N-isopropylacrylamide (NIPAAM), N-vinyl-2-pyrrolidone (VP), and poly(ethyleneglycol) monoacrylate (PEG-A). Physico-chemical characterization confirmed a narrow size distribution of 50 nm. Nanocurcumin demonstrated comparable in vitro efficacy to free curcumin against pancreatic cancer cell lines, with similar mechanisms of action, including apoptosis induction, NFκB inhibition, and downregulation of pro-inflammatory cytokines. In vivo toxicity studies showed no adverse effects, indicating the safety of the formulation. Nanocurcumin's ability to enhance curcumin's solubility and bioavailability makes it a promising candidate for cancer therapy and other diseases. Future studies are needed to evaluate its efficacy in pre-clinical models and to explore its potential in clinical applications.Curcumin, a yellow polyphenol derived from turmeric, has potent anti-cancer properties but is limited by poor solubility and bioavailability. To overcome these challenges, researchers developed "nanocurcumin," a polymeric nanoparticle-encapsulated formulation of curcumin. This formulation allows curcumin to be dispersed in aqueous media, enhancing its therapeutic potential. The nanoparticles were synthesized using cross-linked and random copolymers of N-isopropylacrylamide (NIPAAM), N-vinyl-2-pyrrolidone (VP), and poly(ethyleneglycol) monoacrylate (PEG-A). Physico-chemical characterization confirmed a narrow size distribution of 50 nm. Nanocurcumin demonstrated comparable in vitro efficacy to free curcumin against pancreatic cancer cell lines, with similar mechanisms of action, including apoptosis induction, NFκB inhibition, and downregulation of pro-inflammatory cytokines. In vivo toxicity studies showed no adverse effects, indicating the safety of the formulation. Nanocurcumin's ability to enhance curcumin's solubility and bioavailability makes it a promising candidate for cancer therapy and other diseases. Future studies are needed to evaluate its efficacy in pre-clinical models and to explore its potential in clinical applications.